⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28561507 | 0.70 | — | — | |
| SCHEMBL3706164 | 0.70 | — | — | |
| SCHEMBL2287334 | 0.70 | — | — | |
| SCHEMBL16440003 | 0.65 | — | — | |
| SCHEMBL16439892 | 0.65 | — | — | |
| SCHEMBL41301 | 0.64 | — | — | |
| SCHEMBL3715188 | 0.60 | — | — | |
| SCHEMBL896620 | 0.60 | — | — | |
| SCHEMBL2066991 | 0.60 | — | — | |
| SCHEMBL19917172 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6534512-B1 | A therapeutic method is provided, employing an antiviral compound of the general formula: nucleosides which exhibit antiviral activity. | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2003-03-18 | — | — | US | disclosed |
| US-6072053-A | ANTIVIRAL COMPOUND | UNIV MINNESOTA (US) | 2000-06-06 | — | — | US | disclosed |
| US-5962684-A | Method of preparation of dideoxycarbocyclic nucleosides | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1999-10-05 | — | — | US | disclosed |
| US-5922694-A | SUBSTITUTED-OXY METHYL CYCLOPENTENYL-SUBSTITUTED PURINES AND 8-AZAPURINES ANTI HUMAN IMMUNODEFICIENCY VIRUS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1999-07-13 | — | — | US | disclosed |
| US-5763607-A | VIRICIDES | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1998-06-09 | — | — | US | disclosed |
| US-5631370-A | VIRICIDES FOR HUMAN T-CELL LEUKEMIA/LYMPHOMA | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1997-05-20 | — | — | US | disclosed |
| US-5567703-A | Method for treating HIV infections with dideoxycarbocyclic nucleosides | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1996-10-22 | — | — | US | disclosed |
| US-5175292-A | Viricides, aids | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1992-12-29 | — | — | US | disclosed |
| US-5122517-A | Human t-cell leukemia/lymphoma viruses | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1992-06-16 | — | — | US | disclosed |
| EP-0346132-B1 | PHARMACEUTICAL PRODUCTS | THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1992-03-11 | — | — | EP | disclosed |
| US-4950758-A | ANTIVIRAL AND ANTITUMOR AGENTS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1990-08-21 | — | — | US | disclosed |
| US-4931559-A | VIRICIDES, ANTITUMOR AGENTS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1990-06-05 | — | — | US | disclosed |
| US-4916224-A | VIRICIDES FOR TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTION | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1990-04-10 | — | — | US | disclosed |
| EP-0346132-A1 | Pharmaceutical products | THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1989-12-13 | — | — | EP | disclosed |
| US-4704392-A | VIRICIDES | SYNTEX (U.S.A.) INC. (US) | 1987-11-03 | — | — | US | disclosed |
| US-4605659-A | HERPES; HEPATITUS | SYNTEX (U.S.A.) INC. (US) | 1986-08-12 | — | — | US | disclosed |